T0	Participants 97 205	patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors:
T1	Participants 428 541	patients with rheumatoid arthritis (RA) who had an inadequate response to tumor necrosis factor (TNF) inhibitors.
T2	Participants 550 568	Patients in REFLEX
T3	Participants 681 704	PBO-randomized patients
T4	Participants 1243 1279	480 patients received â‰¥ 1 RTX course